168 related articles for article (PubMed ID: 31042767)
1. Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
Lei K; He X; Yu L; Ni C; Chen H; Guan D; Sun K; Zou H
PLoS One; 2019; 14(5):e0215948. PubMed ID: 31042767
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin suppression therapy using levothyroxine does not negatively affect breast cancer prognosis.
He X; Zhong M; Zhang Q; Aierken N; Cui L; Xing Z; Lei K
Cancer Treat Res Commun; 2022; 31():100525. PubMed ID: 35114502
[TBL] [Abstract][Full Text] [Related]
3. Survival of Patients with First and Metachronous Second Primary Breast Cancer or Lung Cancer Malignancy: Comparisons Using the SEER Database.
Zhong M; He X; Lei K
Adv Ther; 2020 May; 37(5):2236-2245. PubMed ID: 32274747
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database.
Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J
BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815
[TBL] [Abstract][Full Text] [Related]
6. A Possible Association Between Thyroid Cancer and Breast Cancer.
An JH; Hwangbo Y; Ahn HY; Keam B; Lee KE; Han W; Park DJ; Park IA; Noh DY; Youn YK; Cho BY; Im SA; Park YJ
Thyroid; 2015 Dec; 25(12):1330-8. PubMed ID: 26442580
[TBL] [Abstract][Full Text] [Related]
7. Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
Cheng W; Shen X; Xing M
PLoS One; 2019; 14(10):e0221093. PubMed ID: 31644578
[TBL] [Abstract][Full Text] [Related]
8. Effect of breast cancer as the first or second primary cancer on the prognosis of women with thyroid cancer: a SEER database analysis.
Huang J; Huang Y; Zhou L; Chen S; Chen D; Wei W; Zhang C; Wang M; Zhou W; Zeng W; Liu Z; Guo L
Transl Cancer Res; 2020 Nov; 9(11):6955-6962. PubMed ID: 35117303
[TBL] [Abstract][Full Text] [Related]
9. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study.
Yang Q; Wu Z; He X; Yu L; Zhang X; Lei K
Adv Ther; 2019 May; 36(5):1211-1220. PubMed ID: 30879254
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
[TBL] [Abstract][Full Text] [Related]
12. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer in Bedouin-Arab patients in southern Israel: epidemiologic and biologic features in comparison with Jewish patients.
Lazarev I; Flaschner M; Geffen DB; Ariad S
Asian Pac J Cancer Prev; 2014; 15(18):7533-7. PubMed ID: 25292024
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer at extreme ages--a comparative analysis in Chile.
Acevedo F; Camus M; Sanchez C
Asian Pac J Cancer Prev; 2015; 16(4):1455-61. PubMed ID: 25743815
[TBL] [Abstract][Full Text] [Related]
15. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
16. Tubular carcinoma of the breast: institutional and SEER database analysis supporting a unique classification.
Romano AM; Wages NA; Smolkin M; Fortune KL; Atkins K; Dillon PM
Breast Dis; 2015; 35(2):103-11. PubMed ID: 25567000
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors.
Kryzhanivska AE; Dyakiv IB; Kyshakevych I
Exp Oncol; 2018 Jun; 40(2):124-127. PubMed ID: 29949531
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer].
Zhai J; Kong XY; Fang Y; Wang J
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1287-1291. PubMed ID: 34915638
[No Abstract] [Full Text] [Related]
19. Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
Hu ZY; Xiao H; Xiao M; Tang Y; Sun J; Xie ZM; Ouyang Q
Clin Breast Cancer; 2018 Oct; 18(5):e1149-e1163. PubMed ID: 29885789
[TBL] [Abstract][Full Text] [Related]
20. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
